zaki sellam
@zakisellam
Followers
294
Following
65
Statuses
1K
Managing Director at ESN Life Sciences Ltd, Experienced in Business development and wants to share information about biopharma industry
Basel, Switzerland
Joined April 2009
Very good initiative, any healthcare entrepreneur in the swiss and bordering region is welcome to register!
0
0
0
David and Goliath: Biotechs vs. Big Pharma in the Race for First-in-Class Oncology Drugs This nice study analyzed originators of 50 first-in-class oncology drugs approved by FDA from 2010 to 2020. Results show small biotechs and ac…
0
0
0
Proud to have actively contributed to the early set up and financing of BiPER Therapeutics. Landmark BioVentures AG is delivering on its vision to build a portfolio of successful early stage biotech oncology and immunology start up with solid drug develop…
2
0
2
Is chatGPT really going to scare off researchers to that point??? From my perspective nothing will replace real live experimental thinking and data. So why not considering it as a supportive tool in many matters which has to be pro…
0
0
1
Proud to share @Roca Therapeutics announcement that it has closed its seed round. Very good achievement for the first portfolio company of Landmark BioVentures AG. With a clinical candidate already nominated in less than 18 months, we are already preparin…
0
1
1
Long battles for small steps. Analysis of FDA-approved cancer drugs 2003-2021 shows a median improvement in OS of 2.8 mo across 378 indications
0
1
1
Excellent review comprehensively looking at associations between immunological diseases and cancers. Such cross talks between inflammatory and neoplastic disorders
0
1
1
Tomorrow I am moderating a webinar around "Choosing the right translational oncology indication" - When and how to choose an indication? - Can it be purely data driven? - How translational/experimental studies, especially with PDX models could drive such…
0
0
0
The Science of the Deal - "Business Development is more like child-raising than you might think" One year after its first year of its publication, I am very keen to re-share this article as a preliminary insight to my last 7 years part-time academic rese…
0
1
1
"The future of precision oncology is unquestionably one of sophisticated multi-pronged therapeutic attacks by air, by land and by sea." Prof. Douglas Hannahan - author of the famous concept of cancer hallmark Brilliant keynote presentation today at the co…
0
0
0
Very instructive case study about a company having missed its digital transformation. As summarized "Culture, when it comes to a true digital transformation, is like an auto-immune disease: If you inject the new DNA, the organisat…
0
0
1
Very great ejasa conference today around Leadership held in Paris. Inspiring exchanges of experience and practices around Leadership practices and models in healthcare and above all high quality networking. I am proud to be part of that community!!!
0
0
1
Great panel team and discussion at the NETIB2018. Thanks Eric, Georges, Fabien and Jean Pascal!!
0
0
1
Winter Conference 2018. Hurry 4 days left to get the early bird special!
0
0
0
Cellectar Biosciences Signs Collaboration with Avicenna Oncology to Develop New PDCs for Solid Tumors
0
0
0